Xiaobin Wu

President, COO & GM China

Xiaobin Wu (President, COO & GM China) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in BeOne Medicines AG (ONC). The largest single filing was $5.6M of ONC (15,384 sh across 6 lots, as filed), executed Nov 12 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 7 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$8.5M

shares × price, as filed

Last traded

Aug 25

Filed Aug 27

Median ADV $130.5M across their filed names

Open performance→

Volume by month

Buys $0 Sells $77.8M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 7 filings

Sector per market data · by filing · past 12 months

Most traded names

ONC

BeOne Medicines AG ONC · 0 buys · 11 sells 11 filings BGNE BGNE BGNE · 0 buys · 3 sells 3 filings

Recent filings

ONCSALE BeOne Medicines AG View filing → $354K
1,363 sh × $260.00
Exec Jun 23 2025
Filed Jun 25 2025 · 5:30 PM ET ONCSALE BeOne Medicines AG View filing → $541K
2,073 sh across 2 lots
Exec Jun 16 2025
Filed Jun 18 2025 · 5:30 PM ET ONCSALE BeOne Medicines AG View filing → $430K
1,700 sh across 4 lots
Exec Jun 6 2025
Filed Jun 10 2025 · 5:30 PM ET BGNESALE BeiGene, Ltd. View filing → $14.6M
51,921 sh across 4 lots
Exec Apr 1 2025
Filed Apr 3 2025 · 5:30 PM ET BGNESALE BeiGene, Ltd. View filing → $13.5M
51,721 sh across 3 lots
Exec Mar 5 2025
Filed Mar 7 2025 · 5:30 PM ET BGNESALE BeiGene, Ltd. View filing → $12.5M
51,921 sh across 4 lots
Exec Feb 18 2025
Filed Feb 20 2025 · 5:30 PM ET BGNESALE BeiGene, Ltd. View filing → $1.0M
5,000 sh across 2 lots
Exec Sep 17 2024
Filed Sep 19 2024 · 5:30 PM ET